High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system

scientific article published on August 1988

High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.62.8.2718-2727.1988
P932PMC publication ID253705
P698PubMed publication ID3292790

P2093author name stringAlkhatib G
Briedis DJ
P2860cites workProduction of antibodies against measles virions by use of the mouse hybridoma techniqueQ67286145
Hybridization of denatured RNA and small DNA fragments transferred to nitrocelluloseQ24611198
Detection of specific sequences among DNA fragments separated by gel electrophoresisQ25939003
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityQ26778490
A new technique for the assay of infectivity of human adenovirus 5 DNAQ27860797
Selective extraction of polyoma DNA from infected mouse cell culturesQ29547500
RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexaminationQ29547816
In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenovirusesQ33932227
Generation of adenovirus by transfection of plasmidsQ35686623
Adenovirus early region 1A protein activates transcription of a nonviral gene introduced into mammalian cells by infection or transfectionQ36249826
Adenovirus tripartite leader sequence enhances translation of mRNAs late after infectionQ36262361
Complete nucleotide sequence of the neuraminidase gene of influenza B virusQ36320199
Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified proteinQ36857445
Abundant expression of polyomavirus middle T antigen and dihydrofolate reductase in an adenovirus recombinant.Q36886728
Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector.Q36886766
Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunityQ36888993
Measles virus P gene codes for two proteinsQ36899550
Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchorQ36900094
Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus.Q36900467
Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigenQ36918636
Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunityQ36919535
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA.Q37536794
Expression of hepatitis B surface antigen with a recombinant adenovirusQ37554507
Nucleotide sequence analysis of the leader segments in a cloned copy of adenovirus 2 fiber mRNA.Q41674431
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cellsQ41975913
Mechanism of activation of early viral transcription by the adenovirus E1A gene productQ43950071
Influenza B virus RNA segment 8 codes for two nonstructural proteinsQ44459627
Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.Q44693409
Expression of SV40 T antigen under control of adenovirus promotersQ45192720
Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cellsQ45792975
The carboxyterminus of the hemagglutinin-neuraminidase of Newcastle disease virus is exposed at the surface of the viral envelopeQ45795391
Defective interfering particles of sendai virus modulate HN expression at the surface of infected BHK cellsQ45797570
Relationships between Monoclonal Antibody-binding Sites on the Measles Virus HaemagglutininQ45805010
Restriction of cell surface expression of sendai virus hemagglutinin-neuraminidase glycoprotein correlates with its higher instability in persistently and standard plus defective interfering virus infected BHK-21 cellsQ45807288
The predicted primary structure of the measles virus hemagglutininQ45837016
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteinsQ45838770
Studies on the size, chemical composition, and partial sequence of the neuraminidase (NA) from type A influenza viruses show that the N-terminal region of the NA is not processed and serves to anchor the NA in the viral membrane.Q47268687
Cis-acting induction of adenovirus transcriptionQ64380925
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectmeaslesQ79793
AdenoviridaeQ193447
vector-borne diseaseQ2083837
P304page(s)2718-2727
P577publication date1988-08-01
P1433published inJournal of VirologyQ1251128
P1476titleHigh-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system
P478volume62

Reverse relations

cites work (P2860)
Q40456070Adenovirus-mediated gene transfer into striated muscles.
Q34353523Adenoviruses as vaccine vectors
Q27013568Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines
Q36636614Characterization of a cleavage mutant of the measles virus fusion protein defective in syncytium formation
Q37498960Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen
Q35143277Experimental vaccines against measles in a world of changing epidemiology.
Q36881555Expression of bicistronic measles virus P/C mRNA by using hybrid adenoviruses: levels of C protein synthesized in vivo are unaffected by the presence or absence of the upstream P initiator codon
Q36628881Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors.
Q24675302Functional and structural interactions between measles virus hemagglutinin and CD46
Q38728732Future Prospects for the Development of Cost-Effective Adenovirus Vaccines
Q45787436Human parainfluenza virus type 3: Analysis of the cytoplasmic tail and transmembrane anchor of the hemagglutinin-neuraminidase protein in promoting cell fusion
Q33659393Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity
Q41336651Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently
Q64374798Mucosal adenovirus-vectored vaccine for measles
Q37042512Receptors for binding measles virus on host cells and erythrocytes
Q24608200Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells
Q36373305Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.
Q36798265Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene
Q39382203The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles
Q40571045Use of recombinant adenovirus for metabolic engineering of mammalian cells.

Search more.